Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



SCO CAPITAL PARTNERS LLC Create: Alert

All | News | Filings
Date FiledTypeDescription
05/05/2021 4 SCO CAPITAL PARTNERS LLC (10% Owner) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns: Sold 80,000 shares @ $2.0111, valued at $160.9k
03/19/2021 4 SCO CAPITAL PARTNERS LLC (10% Owner) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns: Sold 80,000 shares @ $2.2328, valued at $178.6k
02/19/2021 SC 13D/A SCO CAPITAL PARTNERS LLC reports a 11.8% stake in Abeona Therapeutics Inc.
02/18/2021 4 SCO CAPITAL PARTNERS LLC (10% Owner) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns: Sold 120,000 shares @ $2.9734, valued at $356.8k
02/10/2021 4 SCO CAPITAL PARTNERS LLC (10% Owner) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns: Sold 240,000 shares @ $3.0118, valued at $722.8k
01/19/2021 4 SCO CAPITAL PARTNERS LLC (10% Owner) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns: Sold 31,600 shares @ $2.0004, valued at $63.2k
Sold 81,283 shares @ $2.0187, valued at $164.1k
Sold 207,117 shares @ $2.082, valued at $431.2k
09/17/2020 4 SCO CAPITAL PARTNERS LLC (10% Owner) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns: Sold 1,989 shares @ $2.0017, valued at $4k
09/14/2020 4 SCO CAPITAL PARTNERS LLC (10% Owner) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns: Sold 73,411 shares @ $2.0771, valued at $152.5k
Sold 4,600 shares @ $2.0095, valued at $9.2k
08/21/2020 SC 13D/A SCO CAPITAL PARTNERS LLC reports a 14.1% stake in Abeona Therapeutics Inc.
08/19/2020 4 SCO CAPITAL PARTNERS LLC (10% Owner) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns: Sold 80,000 shares @ $2.8539, valued at $228.3k
05/22/2015 SC 13D/A SCO CAPITAL PARTNERS LLC reports a 47.9% stake in PLASMATECH BIOPHARMACEUTICALS, INC.
01/12/2015 SC 13D/A SCO CAPITAL PARTNERS LLC reports a 66.3% stake in PLASMATECH BIOPHARMACEUTICALS, INC.
12/30/2014 4/A Rouhandeh Steven H (10% Owner) has filed a Form 4 on PLASMATECH BIOPHARMACEUTICALS INC
12/29/2014 4 Rouhandeh Steven H (10% Owner) has filed a Form 4 on PLASMATECH BIOPHARMACEUTICALS INC
03/11/2014 4 Rouhandeh Steven H (10% Owner) has filed a Form 4 on ACCESS PHARMACEUTICALS INC
12/20/2012 4 SCO CAPITAL PARTNERS LLC (10% Owner) has filed a Form 4 on ACCESS PHARMACEUTICALS INC
11/21/2012 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
10/26/2012 4 SCO CAPITAL PARTNERS LLC (10% Owner) has filed a Form 4 on ACCESS PHARMACEUTICALS INC
Txns: Bought 930 options to buy @ $0.5, valued at $464.9
Bought 70 options to buy @ $0.5, valued at $35.2
Bought 18,594,000 warrants @ $0.5, valued at $9.3M
Bought 1,406,000 warrants @ $0.5, valued at $703k
06/19/2009 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]
06/19/2009 4 SCO CAPITAL PARTNERS LLC (10% Owner) has filed a Form 4 on ACCESS PHARMACEUTICALS INC
Txns: Acquired 24,232 shares @ $0
Acquired 101,541 shares @ $0
Acquired 1,510,926 shares @ $0
06/19/2009 4/A Form 4/A - Statement of changes in beneficial ownership of securities [Amend]
02/12/2009 SC 13D/A Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend]
02/06/2009 4 SCO CAPITAL PARTNERS LLC (10% Owner) has filed a Form 4 on ACCESS PHARMACEUTICALS INC
12/22/2008 SC 13D/A Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend]
12/22/2008 SC 13D/A SCO CAPITAL PARTNERS LLC has filed a Schedule 13D for ACCESS PHARMACEUTICALS, INC.
12/19/2008 4 SCO CAPITAL PARTNERS L P (10% Owner) has filed a Form 4 on ACCESS PHARMACEUTICALS INC
12/19/2008 4 SCO CAPITAL PARTNERS L P (10% Owner) has filed a Form 4 on MACROCHEM CORP
11/01/2007 SC 13D/A SEC Filing in the EDGAR database
10/01/2007 SC 13D/A SEC Filing in the EDGAR database
09/12/2007 SC 13D/A SEC Filing in the EDGAR database
07/11/2007 SC 13D/A SEC Filing in the EDGAR database
07/03/2007 SC 13D/A SEC Filing in the EDGAR database
06/27/2007 SC 13D/A SEC Filing in the EDGAR database
06/18/2007 SC 13D/A SEC Filing in the EDGAR database
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy